 | |
| Formerly | Chiros |
|---|---|
| formerly on the London Stock Exchange | |
| Founded | 1991 [1] |
| Founder |
|
| Defunct | 1999 |
| Fate | Acquired by Celltech |
Key people | John Padfield CEO, 1996 [2] |
Chiroscience Group Plc was a British-based biotech company, founded by Christopher Evans. The company was taken over by Celltech in 1999, [3] which was acquired in 2004 by UCB.
Chiroscience was born from the demise of the company Enzymatix, which was ultimately acquired by Genzyme, [4] when Andrew Richards joined the company and convinced Evans and Peter Keen to launch Chiros, name of which was quickly revised to Chrioscience. [3] Seed funding for the company of £3 million was provided by Schroder Ventures, Apax and 3i. [3] Chiroscience became one of the first biotechnology Initial Public Offerings in the United Kingdom in 1994. [3]
In 1996, the company merged with the American biotech company Darwin Molecular Corporation, based in Cambridge, Massachusetts, retaining Chiroscience as its name. [2]
By the time of its merger with Celltech in 1999, [5] both Chris Evans and Peter Keen had left the company, leaving Andrew Richards as the sole remaining founder and original board member. [3]
On Mr. Buffet's terms, Chiroscience is nothing more than a bag of dreams.Contains a graphic showing company stock performance across 1994 to 1996.
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
